Senior Specialist, Clinical Supply Chain- Quality
$120k/y-$150k/y
Revolution Medicines3 days ago
Highlight
OnsiteFull-timeMid
Summary
Revolution Medicines is seeking a Senior Specialist, Clinical Supply Chain- Quality to join their team in the San Francisco Bay Area. The role involves independently supporting global clinical supply chain operations across multiple studies.
About the Role
As a Senior Specialist, Clinical Supply Chain- Quality, you will manage clinical supply chain activities for assigned studies, including planning, execution, and reconciliation. You will support global depot and site distribution, lead clinical label design, and serve as the primary point of contact for CMOs and vendors. Your responsibilities will also include developing study-level supply plans, managing IRT system setup, monitoring IP inventory, and collaborating cross-functionally to ensure timely execution.
About You
Required:
- B.S. in a scientific or supply chain-related field.
- 3–6 years of experience in clinical supply chain and logistics, GMP manufacturing, Quality Assurance, or related pharmaceutical/biotech environment.
- Direct experience in production documentation review, batch disposition and release processes, and QP certification of IMPs.
- Demonstrated experience supporting global clinical trials, including import/export logistics.
- Strong working knowledge of clinical packaging/labeling requirements and temperature-controlled distribution.
- Proficiency in Microsoft Excel.
Preferred:
- Strong attention to detail and ability to critically review complex GMP documentation.
- Prior experience working within a Quality organization strongly preferred.
- Experience interacting with CMOs/external manufacturing partners.
Benefits
- Competitive cash compensation.
- Robust equity awards.
- Strong benefits package including medical, dental, and vision coverage.
- Significant learning and development opportunities.
Revolution Medicines
We are Revolutionaries – passionate in our singular pursuit of discovering, developing and delivering innovative, targeted medicines for patients living with cancer. To deliver on our vision, we work relentlessly in pursuit of cutting-edge therapeutic approaches to some of the toughest cancers. Our current focus is on RAS-addicted cancers, which account for 30 percent of all new human cancer diagnoses.
San Francisco Bay Area